Publication | Closed Access

Trough serum concentrations of β-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of β-lactams

Therapeutic Drug MonitoringPharmacokinetic ModelingAntibioticsTrough Serum ConcentrationsMedicineβ-Lactam AntibioticsPharmacokineticsPharmacotherapyAntimicrobial ChemotherapyAntimicrobial PharmacokineticsCancer PatientsAntimicrobial PharmacodynamicsPharmacologyAntimicrobial ResistancePharmacodynamic Modeling